Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 randomized double-blind intranasal M127101 study in healthy male subjects
jRCT2071230019Phase 1Completed
- Sponsor
- Maruho Co., Ltd.
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in chronic rhinosinusitis with nasal polyps (CRSwNP) comparing M127101 intranasal with Placebo intranasal (2 arms). Primary endpoint: Safety and tolerability. Started Jun 2023; status: completed.
02
Drugs
M127101
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on jRCT2071230019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2071230019.